| Hydrogel‐forming microneedle arrays for enhanced transdermal drug delivery RF Donnelly, TRR Singh, MJ Garland, K Migalska, R Majithiya, ... Advanced functional materials 22 (23), 4879-4890, 2012 | 633 | 2012 |
| Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs MTC McCrudden, AZ Alkilani, CM McCrudden, E McAlister, HO McCarthy, ... Journal of Controlled Release 180, 71-80, 2014 | 247 | 2014 |
| Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery HO McCarthy, J McCaffrey, CM McCrudden, A Zholobenko, AA Ali, ... Journal of Controlled Release 189, 141-149, 2014 | 223 | 2014 |
| Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft JM Senra, BA Telfer, KE Cherry, CM McCrudden, DG Hirst, MJ O'Connor, ... Molecular cancer therapeutics 10 (10), 1949-1958, 2011 | 223 | 2011 |
| TAZ expression as a prognostic indicator in colorectal cancer HF Yuen, CM McCrudden, YH Huang, JM Tham, X Zhang, Q Zeng, ... PloS one 8 (1), e54211, 2013 | 183 | 2013 |
| Arginine‐rich peptide‐based mRNA nanocomplexes efficiently instigate cytotoxic T cell immunity dependent on the amphipathic organization of the peptide VK Udhayakumar, A De Beuckelaer, J McCaffrey, CM McCrudden, ... Advanced healthcare materials 6 (13), 1601412, 2017 | 155 | 2017 |
| Prognostic significance of minichromosome maintenance proteins in breast cancer HF Kwok, SD Zhang, CM McCrudden, HF Yuen, KP Ting, Q Wen, ... American journal of cancer research 5 (1), 52, 2015 | 135 | 2015 |
| The prognostic significance of PD-L1 in bladder cancer Y Huang, SD Zhang, C McCrudden, KW Chan, Y Lin, HFAI KwOK Oncology reports 33 (6), 3075-3084, 2015 | 128 | 2015 |
| Considerations in the sterile manufacture of polymeric microneedle arrays MTC McCrudden, AZ Alkilani, AJ Courtenay, CM McCrudden, ... Drug delivery and translational research 5, 3-14, 2015 | 125 | 2015 |
| DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles AA Ali, CM McCrudden, J McCaffrey, JW McBride, G Cole, NJ Dunne, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 921-932, 2017 | 109 | 2017 |
| Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy S Al-Zahrani, M Zaric, C McCrudden, C Scott, A Kissenpfennig, ... Expert opinion on drug delivery 9 (5), 541-550, 2012 | 92 | 2012 |
| The prognostic significance of Cdc6 and Cdt1 in breast cancer R Mahadevappa, H Neves, SM Yuen, Y Bai, CM McCrudden, HF Yuen, ... Scientific reports 7 (1), 985, 2017 | 90 | 2017 |
| Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays MJ Garland, K Migalska, TM Tuan-Mahmood, TRR Singh, R Majithija, ... International journal of pharmaceutics 434 (1-2), 80-89, 2012 | 87 | 2012 |
| DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen G Cole, AA Ali, E McErlean, EJ Mulholland, A Short, CM McCrudden, ... Acta Biomaterialia 96, 480-490, 2019 | 81 | 2019 |
| DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system G Cole, AA Ali, CM McCrudden, JW McBride, J McCaffrey, T Robson, ... European Journal of Pharmaceutics and Biopharmaceutics 127, 288-297, 2018 | 81 | 2018 |
| In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles J Kennedy, E Larraņeta, MTC McCrudden, CM McCrudden, AJ Brady, ... Journal of Controlled Release 265, 57-65, 2017 | 79 | 2017 |
| Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly (ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo? M Ali, BA Telfer, C McCrudden, M O'Rourke, HD Thomas, M Kamjoo, ... Clinical cancer research 15 (19), 6106-6112, 2009 | 66 | 2009 |
| RALA-mediated delivery of FKBPL nucleic acid therapeutics R Bennett, A Yakkundi, HD McKeen, L McClements, TJ McKeogh, ... Nanomedicine 10 (19), 2989-3001, 2015 | 64 | 2015 |
| Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail‐induced epithelial–mesenchymal transition HF Yuen, YK Chan, C Grills, CM McCrudden, V Gunasekharan, Z Shi, ... The Journal of pathology 224 (1), 78-89, 2011 | 64 | 2011 |
| Influence of alginate backbone on efficacy of thermo-responsive alginate-gP (NIPAAm) hydrogel as a vehicle for sustained and controlled gene delivery MJ Chalanqui, S Pentlavalli, C McCrudden, P Chambers, M Ziminska, ... Materials Science and Engineering: C 95, 409-421, 2019 | 62 | 2019 |
Ryan F DonnellyChair in Pharmaceutical Technology, Queen's University BelfastVerified email at qub.ac.uk
